Innoviva (INVA) Capital Expenditures (2010 - 2026)
Innoviva's Capital Expenditures was $429,000 in Q2 2026, down 12.8% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Capital Expenditures (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Innoviva's Capital Expenditures was $2.05 million through Jun 30, 2026, up 660.0% year-over-year; for FY2025, it was $1.13 million, up 318.9% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of 144.3% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $270,000 in FY2024 (-34.3%), $411,000 in FY2023 (+513.4%) and $67,000 in FY2022.
- Quarterly Capital Expenditures has moved between $9,000 (Q1 2022) and $1.12 million (Q3 2025) over five years.
- Per Business Quant data, INVA's Capital Expenditures in the three quarters before Q2 2026 was $492,000 (Q1 2026), $10,000 (Q4 2025) and $1.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Innoviva | 1.53 Bn | -757.39 Mn | 90.62 Mn | 429,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 429,000.00 |
| Mar 31, 2026 | 492,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 1.12 Mn |
| Sep 30, 2024 | 270,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Mar 31, 2020 | 13,000.00 |
| Dec 31, 2019 | 12,000.00 |
| Dec 31, 2016 | 28,000.00 |
| Sep 30, 2016 | 242,000.00 |
| Jun 30, 2016 | 8,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Mar 31, 2015 | 6,000.00 |
| Dec 31, 2014 | 133,000.00 |
| Jun 30, 2014 | -1.06 Mn |
| Mar 31, 2014 | 1.62 Mn |
| Dec 31, 2013 | 1.07 Mn |
| Sep 30, 2013 | 236,000.00 |
API Access
Innoviva Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();